Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Sheel Bio.
Quarter-by-quarter operating performance
Financials of Sheel Bio.
Annual income statement trend
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales + | 63 | 84 | 89 | 103 | 110 | 110 |
| Expenses + | 56 | 78 | 80 | 89 | 95 | 94 |
| Operating Profit | 7 | 6 | 9 | 14 | 15 | 16 |
| OPM % | 10% | 8% | 10% | 14% | 14% | 15% |
| Other Income + | 0 | 0 | 0 | 0 | 1 | 1 |
| Interest | 1 | 1 | 2 | 1 | 2 | 2 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 5 | 5 | 6 | 12 | 13 | 14 |
| Tax % | 0% | 2% | 20% | 15% | 17% | 16% |
| Net Profit + | 5 | 5 | 5 | 10 | 11 | 12 |
| EPS in Rs | 11.58 | 10.88 | 12.26 | 25.27 | 7.12 | 5.78 |
| Dividend Payout % | 0% | 28% | 25% | 12% | 14% | 0% |
Financials of Sheel Bio.
Capital structure and asset base
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|
| Equity Capital | 4 | 4 | 4 | 4 | 15 | 15 |
| Reserves | 53 | 56 | 59 | 69 | 69 | 69 |
| Borrowings + | 21 | 24 | 19 | 24 | 17 | 27 |
| Other Liabilities + | 4 | 10 | 11 | 10 | 12 | 13 |
| Total Liabilities | 82 | 93 | 94 | 106 | 113 | 124 |
| Fixed Assets + | 8 | 8 | 8 | 7 | 7 | 7 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 1 | 1 | 1 | 1 | 1 |
| Other Assets + | 75 | 84 | 85 | 98 | 105 | 116 |
| Total Assets | 82 | 93 | 94 | 106 | 113 | 124 |
Financials of Sheel Bio.
Operating, investing and financing cash movement
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 2 | 9 | -1 | 9 | ||
| Cash from Investing Activity + | -2 | -2 | -0 | -2 | ||
| Cash from Financing Activity + | -0 | -7 | 2 | -7 | ||
| Net Cash Flow | -0 | -0 | 0 | -0 | ||
| Free Cash Flow | 1 | 8 | -1 | 8 | ||
| CFO/OP | 37% | 105% | 3% | 75% |
Financials of Sheel Bio.
Working capital efficiency and return ratios
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor Days | 352 | 280 | 230 | 204 | 182 | |
| Inventory Days | 55 | 120 | 177 | 263 | 272 | |
| Days Payable | 30 | 85 | 75 | 37 | 29 | |
| Cash Conversion Cycle | 377 | 315 | 332 | 430 | 426 | |
| Working Capital Days | 348 | 274 | 255 | 256 | 253 | |
| ROCE % | 7% | 10% | 15% | 14% |
Radiant Acemoney has a healthy order pipeline for the current and next quarters, with 60%-70% already in the order book. Key concall takeaways from Radiant…
Movement Hire volumes grew 8% in Q1 FY27, moving from 711,000 to 766,000 pallets. Key concall takeaways from Leap India Ltd's Q1 FY27 earnings call — and how…
170 crores to Rs. Key concall takeaways from Creative Newtech Ltd's Q4 FY24 earnings call — and how it ranks against sector peers.
Long-term goal: Annual PAT growth of 30%-40%, improve EBIT margins, and achieve INR2,000 crores revenue with 4%-4.5% EBIT margin in future years. Key concall…